Evidence map›Paper›PMID 42701388›Full record

ArticleClinical case reports2026

Sporadic Retinal Astrocytic Hamartoma Mimicking Retinoblastoma in a Child: A Case Report and Literature Review.

Mesfin Wubishet Gurmu, Samuel Negash, Aneso Mohammed, Hailu Alemu, Diriba Fufa Hordofa, Melese Abere, Lensa Million, Esubalew Mezgebu

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mesfin Wubishet GurmuDepartment of Pediatrics Arsi University College of Health Sciences Asella Ethiopia.ORCID https://orcid.org/0009-0004-8758-9424
Samuel NegashDepartment of Pediatrics, Division of Pediatric Hematology-Oncology Jimma University Medical Center Jimma Ethiopia.
Aneso MohammedDepartment of Pediatrics, Division of Pediatric Hematology-Oncology Jimma University Medical Center Jimma Ethiopia.ORCID https://orcid.org/0009-0005-3456-9830
Hailu AlemuDepartment of Pediatrics, Division of Pediatric Hematology-Oncology Jimma University Medical Center Jimma Ethiopia.
Diriba Fufa HordofaDepartment of Pediatrics, Division of Pediatric Hematology-Oncology Jimma University Medical Center Jimma Ethiopia.
Melese AbereDepartment of Pathology Jimma University Medical Center Jimma Ethiopia.
Lensa MillionDepartment of Clinical Radiology Jimma University Medical Center Jimma Ethiopia.
Esubalew MezgebuDepartment of Pediatrics, Division of Pediatric Hematology-Oncology Jimma University Medical Center Jimma Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal astrocytichamartoma (RAH) is a rare benign glial neoplasm most commonly associated with tuberous sclerosis complex (TSC). Sporadic cases, occurring in the absence of systemic phakomatosis, are uncommon and may closely mimic retinoblastoma, particularly when presenting with a calcified intraocular mass, creating a diagnostic challenge with potentially irreversible therapeutic consequences. We report a 6-year-old boy with progressive exotropia and complete visual loss in the right eye. Multimodal imaging revealed a calcified posterior intraocular mass with diffusion restriction and contrast enhancement on MRI, features highly suspicious for retinoblastoma. Given the high radiologic suspicion of malignancy, the absence of residual visual potential, and the unavailability of optical coherence tomography, primary enucleation of the right eye with orbital implant placement was performed. Histopathological and immunohistochemical evaluation demonstrated astrocytic proliferation with focal glialfibrillary acidic protein (GFAP) positivity and synaptophysin negativity, favoring RAH; however, the unavailability of cone-rod homeobox (CRX) and other neuronal markers precluded definitive exclusion of well-differentiated retinoblastoma. The postoperative course was uneventful, and at one-year follow-up the patient remained clinically stable with no recurrence or intracranial pathology on MRI. This case illustrates the difficulty of differentiating sporadic RAH from retinoblastoma in young children when advanced diagnostics are limited, and underscores the need to weigh over treatment of a benign lesion against the risk of an unrecognizedintraocular malignancy. Expanding access to OCT and comprehensive immunohistochemistry is essential to reduce diagnostic uncertainty and unnecessary enucleation.

Indexed as

enucleationimmunohistochemistryintraocular tumorsoptical coherence tomographyretinal astrocytic hamartomaretinoblastomatuberous sclerosis complex

Identifiers

PMID42701388
PMCPMC13545270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.